Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.38 USD | -7.99% | -21.14% | +144.27% |
09/05 | Earnings Flash (NKTR) NEKTAR THERAPEUTICS Reports Q1 Revenue $21.6M, vs. Street Est of $15.3M | MT |
09/05 | Transcript : Nektar Therapeutics, Q1 2024 Earnings Call, May 09, 2024 |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+144.27% | 254M | |
+39.22% | 731B | |
+32.14% | 586B | |
-7.85% | 348B | |
+15.48% | 319B | |
-0.12% | 273B | |
+13.32% | 235B | |
+7.42% | 202B | |
-7.12% | 203B | |
-3.37% | 158B |
- Stock Market
- Equities
- NKTR Stock
- News Nektar Therapeutics
- Transcript : Nektar Therapeutics Presents at JPMorgan 40th Annual Healthcare Conference, Jan-11-2022 03